Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New Podcast CE Alert: "Medications for Opioid Use Disorder" is now available! Listen for FREE now. Subscribers can earn CE credits just for listening and passing a short quiz.
Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Pediatrics
  4. Neurology & Psychiatry
  5. Other

Other

  • Antibiotics & Antivirals (82)
  • Autism (31)
  • Cough, Cold & Fever (166)
  • Gastroenterology (42)
  • Lice & Scabies (19)
  • Neurology & Psychiatry (101)
    • ADHD/ADD (67)
    • Depression (11)
    • Febrile Seizures (5)
    • Other (21)
  • Other (116)
  • Poison Prevention (73)
  • Rash (5)
  • Resources (189)
  • Vaccines (162)
1 - 15 of 21 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Comparison of Atypical Antipsychotics (United States) October 2023
Chart: Comparison of Atypical Antipsychotics (Canada) October 2023
Article: Think of Meds as Last-Line for Migraine Prophylaxis in Kids April 2020
Chart: Pediatric Migraine Prevention April 2020
Chart: Management of Autism-Related Symptoms January 2020
Article: Feel Comfortable Recommending Triptans for Kids With Migraines April 2019
FAQ: Treatment of Pediatric Migraine April 2019
Article: Demystify Cannabidiol Oil September 2018
PL Voices: The Role of Cannabidiol September 2018
FAQ: Comparison of Cannabinoids September 2018
Article: Don't Let New Generics for Abilify Tempt You to Recommend It More Liberally July 2015
Chart: Off-Label Use of Atypical Antipsychotics in Adults July 2015
PL Voices: Strategies for Preventing Migraines in Kids and Teens June 2014
Article: more focus on PREVENTING migraines in kids and teens...especially now that Topamax (topiramate) is approved for ages 12 and up June 2014
Commentary: Pharmacotherapy of Pediatric Anxiety January 2014
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved